In patients with T2DM and obesity, insulin fails to appropriately regulate hepatic metabolism, leading to excess production of glucose despite accelerated rates of lipid synthesis, a condition commonly referred to as selective hepatic IR [69]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.